Sarepta Therapeutics, Inc. · NASDAQ:SRPT
State Street Corp reported a 8.40% stake in Sarepta Therapeutics, Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Aug 7, 2026
State Street Corp reported a 8.40% stake in Sarepta Therapeutics, Inc., 8,916,103 shares, as a passive investor on Jun 30, 2026. Filed Aug 7, 2026 (Schedule 13G).
- Stake
- 8.40%
- Shares
- 8,916,103
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| STATE STREET CORPORATION | 8.40% | 8,916,103 |
| SSGA FUNDS MANAGEMENT, INC. | 6.00% | 6,285,547 |
Source
Related
- Sarepta Therapeutics, Inc.
- State Street Corp
- Sarepta Therapeutics, Inc. shareholders
- Schedule 13G · State Street Corp · Nov 10, 2025
- Form 4 · Wong Ryan Ho-Yan · Sep 8, 2026
- Form 4 · Estepan Ian Michael · Sep 8, 2026
- Form 4 · Rothfuss Cristin · Sep 8, 2026
- Form 4 · Rodino-Klapac Louise · Sep 8, 2026
- Schedule 13G/A · AQR Capital Management LLC · Aug 13, 2026